Sino Biopharmaceutical Limited (SBMFF) ROE US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ? 5 years average
ROE, % ? 48.2% 8.55% 7.65% 11.0% 7.44%   11.8%  
Changes by years, y/y, % +32pp -40pp -1pp +3pp -4pp     +17%

Sino Biopharmaceutical Limited. ROE, %

Sino Biopharmaceutical Limited. ROE, changes, pp

Sino Biopharmaceutical Limited (SBMFF) ROE US GAAP (quarter values)

FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1 FY2026Q2   LTM ?
ROE, % ? 11.6% 10.1% 7.64% 7.27% 7.34%   11.8%
Changes by years, y/y, % -1pp -2pp -3pp -4pp -4pp    
Changes by quarters, q/q, % +1pp -1pp -2pp 0pp +0pp    

Sino Biopharmaceutical Limited. ROE, %

Sino Biopharmaceutical Limited. ROE, changes, pp

Sino Biopharmaceutical Limited. ROE, changes, pp